Meta-analysis of steady-state pharmacokinetics of troglitazone and its metabolites.
about
Hepatocellular exposure of troglitazone metabolites in rat sandwich-cultured hepatocytes lacking Bcrp and Mrp2: interplay between formation and excretion.Investigations toward enhanced understanding of hepatic idiosyncratic drug reactions.Interactions between simvastatin and troglitazone or pioglitazone in healthy subjects.Lack of effect of type II diabetes on the pharmacokinetics of troglitazone in a multiple-dose study.Steady-state pharmacokinetics and dose proportionality of troglitazone and its metabolites.
P2860
Meta-analysis of steady-state pharmacokinetics of troglitazone and its metabolites.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Meta-analysis of steady-state pharmacokinetics of troglitazone and its metabolites.
@en
Meta-analysis of steady-state pharmacokinetics of troglitazone and its metabolites.
@nl
type
label
Meta-analysis of steady-state pharmacokinetics of troglitazone and its metabolites.
@en
Meta-analysis of steady-state pharmacokinetics of troglitazone and its metabolites.
@nl
prefLabel
Meta-analysis of steady-state pharmacokinetics of troglitazone and its metabolites.
@en
Meta-analysis of steady-state pharmacokinetics of troglitazone and its metabolites.
@nl
P2093
P2860
P1476
Meta-analysis of steady-state pharmacokinetics of troglitazone and its metabolites.
@en
P2093
P2860
P304
P356
10.1002/J.1552-4604.1997.TB04285.X
P577
1997-11-01T00:00:00Z